CLINICAL_TRIALS
trial_result
· 2022-11-04
Clinical Trial Update: Methylene Blue in Early Septic Shock [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates on methylene blue for septic shock have been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital Civil de Guadalajara | Conditions: Septic Shock | Phase 2, Phase 3 | Status: COMPLETED